posted on 2024-04-13, 02:13authored byYaroslav Lyutvinskiy, Konstantin O. Nagornov, Anton N. Kozhinov, Natalia Gasilova, Laure Menin, Zhaowei Meng, Xuepei Zhang, Amir Ata Saei, Tingting Fu, Julia Chamot-Rooke, Yury O. Tsybin, Alexander Makarov, Roman A. Zubarev
Traditionally, mass spectrometry (MS) output is the ion
abundance
plotted versus the ionic mass-to-charge ratio m/z. While employing only commercially available equipment,
Charge Determination Analysis (CHARDA) adds a third dimension to MS,
estimating for individual peaks their charge states z starting from z = 1 and color coding z in m/z spectra. CHARDA combines
the analysis of ion signal decay rates in the time-domain data (transients)
in Fourier transform (FT) MS with the interrogation of mass defects
(fractional mass) of biopolymers. Being applied to individual isotopic
peaks in a complex protein tandem (MS/MS) data set, CHARDA aids peptide
mass spectra interpretation by facilitating charge-state deconvolution
of large ionic species in crowded regions, estimating z even in the absence of an isotopic distribution (e.g., for monoisotopic
mass spectra). CHARDA is fast, robust, and consistent with conventional
FTMS and FTMS/MS data acquisition procedures. An effective charge-state
resolution Rz ≥
6 is obtained with the potential for further improvements.